Publication:


abstract

PURPOSE:

The goal of this work was to analyze the response rate and outcome of patients with stage I-III follicular lymphoma (FL) treated with Radiotherapy (RT) alone.

PATIENTS AND METHODS:

The records of 50 consecutive patients with stage I-III FL treated with RT alone at our department from 1988-2009 were analyzed. The median age was 60 years (range 32-80 years) with a median follow-up duration of 8 years (range 4-11 years). Clinical staging was performed according to the Ann Arbor system. Stage I: 30 patients (60%), stage II: 15 patients (30%), stage III: 5 patients (10%). Thirty-two patients (64%) presented with nodal disease, 14 patients (28%) presented with disease in extranodal sites, and 4 patients (8%) had nodal and extranodal involvement. The RT field encompassed only the involved Ann Arbor nodal regions (involved-field RT) in 26 patients (52%), mantle and whole abdominopelvic fields in 6 patients (12%), mantle field in 10 patients (20%), whole abdominopelvic fields in 5 patients (10%), and a so-called mini-mantle in 3 patients (6%). The total RT dose ranged from 26-56 Gy (median 40 Gy) in daily fractions of 1.2-2.5 Gy.

RESULTS:

Complete remission (CR) and partial remission (PR) were observed in 39 (76%) and 9 (20%) patients, respectively. Only 2 of 8 patients (25%) with tumor bulk > 5 cm reached CR, whereas 37 of 42 patients (88%) with a maximum lymphoma diameter < 5 cm achieved CR (p = 0.0001). The median overall survival (OS) and median event-free survival (EFS) were 18 years (CI 95% 10-26 years) and 7 years (6-8 years), respectively. The 2-, 5-, and 10-year OS were 96 ± 3%, 90 ± 5%, and 70 ± 9%, respectively. The 2-, 5-, and 10-year EFS were 90 ± 5%, 70 ± 7%, and 38 ± 9%, respectively. Fifteen patients developed a recurrence outside the radiation field (30%) and 4 patients developed an in-field recurrence (8%). All in-field recurrences were observed in regions without clinical (macroscopic) involvement, which were irradiated with a dose of ≤ 26 Gy. Pretreatment maximum lymphoma diameter < 5 cm (p = 0.039) and complete remission after RT (p = 0.021) were significantly associated with a better OS in the univariate analysis.

CONCLUSION:

RT is a curative option in the treatment of limited stage FL. If RT of microscopically uninvolved area is necessary, a reduction in the radiation dose should be carefully weighed against the risk of in-field recurrences.

Related Articles
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
Int J Radiat Oncol Biol Phys. ...
Long-term results with radiotherapy for Stage I-II follicular lymphomas.
Wilder RB, Jones D, Tucker SL, Fuller LM, Ha CS, McLaughlin P, Hess MA, Cabanillas F, Cox JD. Int J Radiat Oncol Biol Phys. 2001 Dec 1; 51(5):1219-27.
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
Tumori. 2005
Localized extranodal lymphoma of the head and neck: retrospective analysis of a series of 107 patients from a single institution.
Frata P, Buglione M, Grisanti S, Bonetti B, Vitali E, De Stefani A, Magri E, Peveri A, Marini G, Rossi G, et al. Tumori. 2005 Nov-Dec; 91(6):456-62.
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Int J Radiat Oncol Biol Phys. ...
Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM, Wilder RB, Tucker SL, Ha CS, Younes A, Fayad L, Rodriguez MA, Hagemeister FB, Barista I, Cabanillas F, et al. Int J Radiat Oncol Biol Phys. 2003 Jan 1; 55(1):36-43.
Review Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Leuk Lymphoma. 1999
Review Limited stage I and II follicular non-Hodgkin's lymphoma: the Nebraska Lymphoma Study Group experience.
Tezcan H, Vose JM, Bast M, Bierman PJ, Kessinger A, Armitage JO. Leuk Lymphoma. 1999 Jul; 34(3-4):273-85.
Review Nodal follicular lymphoma: the role of radiotherapy for stages I and II.
Strahlenther Onkol. 2010
Review Nodal follicular lymphoma: the role of radiotherapy for stages I and II.
Heinzelmann F, Engelhard M, Ottinger H, Bamberg M, Weinmann M. Strahlenther Onkol. 2010 Apr; 186(4):191-6. Epub 2010 Mar 26.